Mycetoma is a chronic disabling disease that's one of the most neglected in the world. But there is hope for patients: results from a clinical trial conducted by DNDi in partnership with the Mycetoma Research Center, Erasmus MC, and Eisai Co., Ltd. show that a new oral treatment is safe, patient-friendly, and effective in treating the disease. See people with mycetoma share their experience and find out what researchers and doctors discovered in their research.